Clinical trial
A Prospective, Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Safety and Efficacy of a Single-Use Intravascular Ultrasound Ablation Catheter and Ultrasound Ablation System in the Treatment of Primary Hypertension
NCT07051811 is registered in ClinicalTrials.gov with Lepu Medical Technology (Beijing) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Safety and Efficacy of a Single-Use Intravascular Ultrasound Ablation Catheter and Ultrasound Ablation System in the Treatment of Primary Hypertension
- Lead sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 25, 2025
- Completion date
- December 31, 2029
- Enrollment
- 213 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.